Trinity Biotech
Business Services · Ireland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Ida Business Park, Bray, Leinster, A98 H...Phone Number
+353 8003253424Website
www.trinitybiotech.comRevenue
$61.6 MillionStock Symbol
TRIBIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
2
1
1
1
About Trinity Biotech
Trinity Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has recently entered the wearable biosensor industry, with the acquisition of the biosensor assets of Waveform Technologies Inc. and intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Our products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States and through a network of international distributors and strategic partners in over 75 countries worldwide.Explore more
Trinity Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Trinity Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Trinity Biotech had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Trinity Biotech has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Trinity Biotech is spiking on competitors!
Product Launch: Get notified when Trinity Biotech launches new products
Earning: See what the market has to say on Trinity Biotech recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Trinity Biotech
Funding: Get notified immidiatlly once Trinity Biotech has new funding data
Trinity Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Trinity Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Trinity Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Trinity Biotech.
Trinity Biotech financials insights
Gather financial insights about Trinity Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Debt
$115M
2022
Corporate Investment
$45M
2023
Debt
$5M
2024
Other Financing Round
$5.5M
2025
Debt
$4M
Debt
$5M
2026
Unspecified
$25M
Trinity Biotech Tech Stack
A closer look at the technologies used by Trinity Biotech
Most Recent Scoops
Person-Based
Earnings, Pharmaceuticals, Finance
Person-Based
Earnings, Pharmaceuticals, Finance
Person-Based
Person-Based
Medical Research
Person-Based
Product Launch, Machine Learning, Medical Research, Clinical Operations
Trinity Biotech News & Media
Trinity Biotech’s Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling
- Milestone an important step in launching Trinovium within the global AI data center ecosystemTrinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville
DUBLIN, June 29, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on human diagnostics and the development of innovative solutions addressing unmet clinical and industrial needs, today announced that it has formally provided notice of termination to YA II PN, LTD., an affiliate of financing partner Yorkville Advisors Global, in respect of its Standby Equity Purchase Agreement (the “SEPA”) for an equity line of credit facility.Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market
- New subsidiary will leverage existing US and EU manufacturing capacity, high-purity fluid expertise, and analytical technologies to target liquid cooling performance and reliability in AI and high-performance computing environmentsTrinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results
– Orders reinforce strong demand outlook in global health markets and supports 2026 revenue and profitability targets
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Trinity Biotech
Sign Up For FreeTo access detailed company insights
Trinity Biotech is a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic... Read More
